Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
1,934,532
-
Share change
-
+1,934,532
-
Total reported value
-
$19,037,000
-
Price per share
-
$9.84
-
Number of holders
-
13
-
Value change
-
+$19,037,000
-
Number of buys
-
13
Institutional Holders of REVIVA PHARMACEUTCLS HLDGS INC COM - Stock (TZAC) as of Q4 2018
As of 31 Dec 2018,
REVIVA PHARMACEUTCLS HLDGS INC COM - Stock (TZAC) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,934,532 shares.
The largest 10 holders included
OXFORD ASSET MANAGEMENT LLP, MIZUHO SECURITIES USA LLC, Periscope Capital Inc., City Financial Investment Co Ltd, Weiss Asset Management LP, GOLDMAN SACHS GROUP INC, PANAGORA ASSET MANAGEMENT INC, HGC Investment Management Inc., Bulldog Investors, LLC, and BASSO CAPITAL MANAGEMENT, L.P..
This page lists
13
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.